CAS: 26944-48-9; Glibornuride

专利信息

专利号:US-5900227-A
优先权日:1996-06-17
标题 :Multicyclic nitrone spin trapping compositions
发明人：JANZEN EDWARD G; SANKURATRI NAGARAJU
权利人:OKLAHOMA MED RES FOUND
摘要:Multicyclic nitrone spin trapping compounds capable of forming stable free radical spin adducts are provided as well as methods for their synthesis. The multicyclic nitrone spin trapping compounds can be reacted with a free radical, such as a hydroxy or hydroperoxy radical, in solution to form a spin adduct which is stable and readily detectable by electron paramagnetic resonance (EPR) spectroscopy. The multicyclic nitrone spin traps can be used to detect free radicals in a sample such as a biological system. In one embodiment, the spin trapping compound, 1,3,3-trimethyl-6-azabicyclo-[3.2.1]oct-6-ene-N-oxide ('TRAZON') is provided, as well as methods for the synthesis of TRAZON and of modified forms of TRAZON. TRAZON can react with a wide range of different free radicals in solution to form free radical spin adducts which are readily detectable by EPR.

专利号:WO-2025096684-A1
优先权日:2023-10-30
标题 :Err modulators
发明人：ELGENDY BAHAA; HEGAZY LAMEES; BURRIS THOMAS
权利人:UNIV OF HEALTH SCIENCES AND PHARMACY IN ST LOUIS
摘要:In one aspect, the present disclosure describes compounds which may be used to modulate the activity of an estrogen receptor-related orphan receptor (EER). Also described are pharmaceutical formulations, methods of synthesis and uses thereof.

专利号:WO-2025096683-A1
优先权日:2023-10-30
标 题:Err modulators
发明人：ELGENDY BAHAA; HEGAZY LAMEES SHAMSELDIN; BURRIS THOMAS PATRICK
权利人:UNIV OF HEALTH SCIENCES AND PHARMACY IN ST LOUIS
摘要:In one aspect, the present disclosure describes compounds that may be used to modulate the activity of an estrogen receptor-related orphan receptor (EER). Also described are pharmaceutical formulations, methods of synthesis and uses thereof.

专利号:EP-0348490-B1
优先权日:1988-01-11
标题 :Treatment of type 2 diabetes mellitus
发明人：COOPER GARTH JAMES SMITH; GREENE HOWARD E
权利人:AMYLIN PHARMACEUTICALS INC
摘要:Compounds and methods for blocking the effects of diabetes-associated peptide, or ''amylin'', a hormone found in the amyloid masses of Type 2 diabetics. Also disclosed are methods of identifying additional compounds having utility for the treatment of Type 2 diabetes. This putative hormone has been discovered to function both to inhibit insulin secretion and to inhibit glycogen synthesis. Regulation is accomplished by blocking the binding of amylin or amylin agonists, including calcitonin gene related peptide (CGRP), or biologically active sub-peptides thereof. Inhibitors include substituted peptides or sub-peptides of amylin or CGRP, cross-linked amylin and amylin agonists, synthetic amylin, anti-amylin receptor antibodies and anti-idiotype antibodies, and antibodies directed to amylin and amylin agonist active sites. Other antagonists include organic compounds which can be screened and assayed for anti-amylin effects by disclosed methods.

专利号:US-8933207-B2
优先权日:2010-07-28
标 题 :Drug-ligand conjugates, synthesis thereof, and intermediates thereto
发明人：CHEN ZHIYU; LANCASTER THOMAS M; ZION TODD C
权利人:CHEN ZHIYU; LANCASTER THOMAS M; ZION TODD C; SMARTCELLS INC
摘要:The present invention relates to methods for synthesizing compounds of formula I or pharmaceutically acceptable salts thereof: I wherein each of X, Alk 1 , Alk 2 , and W are as defined and described herein.

专利号:US-2004082548-A1
优先权日:1999-04-01
标 题 :Intermediates for the synthesis of ether compounds